A. Post-infectious Glomerulonephritis
B. Myoglobinuria due to rhabdomyolysis
C. Paroxysmal nocturnal hemoglobinuria
D. Benign Tubular Proteinuria
E. Goodpasteure's Syndrome
A. Focal Segmental Glomerulosclerosis (FSGS)
B. Wegener's Granulomatosis
C. Cryoglobulinemia
D. Post-streptococcal Glomerulonephritis
E. Systemic Lupus Erythematosus
A. Renal Biopsy
B. Anti-neutrophil cytoplasmic antibody test
C. DNAse and anti-streptolysin O titers
D. Hepatitis B and C titers
E. Antinuclear antibody test
A. Plasmapheresis
B. Cyclophosphamide intravenously
C. High dose glucocorticoids intravenously
D. Dialysis
E. Cyclosporine 5mg/kg intravenously
A. Repiratory acidosis and metabolic acidosis
B. Respiratory alkalosis and metabolic acidosis
C. Respiratory acidosis and metabolic alkalosis
D. Metabolic acidosis alone
E. Respiratory acidosis alone
Her serum sodium remained below 132mM for three days. On the third hospital day, her blood pressure dropped to 90/75mm and she became confused. Intravenous normal saline was given and the blood pressure came up to 105/70mm with improvement in the mental status. The serum sodium was 129mM later that evening after 3 liters of normal saline. The BUN was 18mg/dL and creatinine was 1.2mg/dL, and the potassium was 3.6mM. |
A. Hypovolemia
B. Adrenal Insufficiency
C. Thyroid Disease
D. Underlying renal disease
E. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
A. Gentamicin toxicity
B. Gentamicin and Ceftazidime toxicity
C. Renal Immune Complex Disease from infection
D. Acute Tubular Necrosis due to hypotension
E. SIADH
A. She will decline and require dialysis within 1 week
B. She will progress to dialysis within 3 months
C. Her renal function will improve to baseline or nearly baseline
D. Her renal function will stabilize at the current level
E. Her renal function will worsen slightly then stabilize
A. Cholesterol Emboli Syndrome
B. Systemic Vasculitis
C. Allergic Reaction to Radiocontrast Material
D. Radiocontrast Nephropathy
E. Acute post-infectious glomerulonephritis
TOPIC CARD REFERENCES |